Moderna mRNA-1273 vaccine damage calculations

Currently waiting for a response from Department for Work and Pensions, they should respond promptly and normally no later than (details).

Dear Department for Work and Pensions,

According to mainstream media sources the UK Government have purchased 5 million doses of the Moderna novel lipid nanoparticle-encapsulated, nucleoside-modified RNA vaccine mRNA-1273 that will be the first of it’s kind to be used in treat a disease that has an average age of death of over 80 years of age (79.9 years for males in Scotland according to recent information from the National Records of Scotland).

The British public will be sufficiently phlegmatic and pragmatic to realise that the DWP will budget for vaccine injuries prior to vaccine purchase.

What are the currently recorded estimates for the number severe adverse events and injuries that are anticipated for the Moderna novel lipid nanoparticle-encapsulated, nucleoside-modified RNA vaccine mRNA-1273?

Yours faithfully,

J Grove

DWP freedom-of-information-requests, Department for Work and Pensions

This is an automated confirmation that your request for information has
been accepted by the DWP FOI mailbox.
 
If your email is a Freedom of Information request you can normally expect
a response within 20 working days.
 
However please be advised that due to the current situation with COVID-19
we cannot guarantee a response within this timescale.
 
Every effort is being made to respond to FOIs as we would usually but the
current situation means that available Departmental resources will be
needed on other high priority areas.
 
We kindly ask for your understanding during this unprecedented situation
and we will aim to deal with your FOI request as soon as is practically
possible.
 
Email FOI responses will be issued from [1][email address]
We recommend that you add this address to your email contacts otherwise
the response may be treated as Spam or Junk mail.  
 
Should you have any further queries in connection with this request do
please contact us.
 
[2]http://www.gov.uk/dwp
 
 

show quoted sections

References

Visible links
1. mailto:[email address]
2. http://www.gov.uk/dwp

Dear Department for Work and Pensions,

To further clarify this request the estimate asked for is based on the recent reports from the Medicines & Health Products Agency (MHPA) that detail that they may not be able to source the prerequite Artificial Intelligence (AI) software required to monitor to anticipated high number of Adverse Drug Reactions (ADR) that are expected from a COVID-19 vaccine.

The DWP should have factored this into their budgets.

Yours faithfully,

J Grove

DWP freedom-of-information-requests, Department for Work and Pensions

This is an automated confirmation that your request for information has
been accepted by the DWP FOI mailbox.
 
If your email is a Freedom of Information request you can normally expect
a response within 20 working days.
 
However please be advised that due to the current situation with COVID-19
we cannot guarantee a response within this timescale.
 
Every effort is being made to respond to FOIs as we would usually but the
current situation means that available Departmental resources will be
needed on other high priority areas.
 
We kindly ask for your understanding during this unprecedented situation
and we will aim to deal with your FOI request as soon as is practically
possible.
 
Email FOI responses will be issued from [1][email address]
We recommend that you add this address to your email contacts otherwise
the response may be treated as Spam or Junk mail.  
 
Should you have any further queries in connection with this request do
please contact us.
 
[2]http://www.gov.uk/dwp
 
 

show quoted sections

References

Visible links
1. mailto:[email address]
2. http://www.gov.uk/dwp

Bartholomeus Lakeman left an annotation ()

In Oct. the European Ted published that MHRA urgently seeks an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs) and ensure that no details from the ADRs’ reaction text are missed. AI including 48000000 Software package and information systems.
Award of a contract without prior publication of a call for competition in the Official Journal of the European Union in the cases listed below
• The procurement falls outside the scope of application of the directive
Explanation: For reasons of extreme urgency under Regulation 32(2)(c) related to the release of a Covid-19 vaccine MHRA have accelerated the sourcing and implementation of a vaccine specific AI tool.
Strictly necessary — it is not possible to retrofit the MHRA’s legacy systems to handle the volume of ADRs that will be generated by a Covid-19 vaccine. Therefore, if the MHRA does not implement the AI tool, it will be unable to process these ADRs effectively. This will hinder its ability to rapidly identify any potential safety issues with the Covid-19 vaccine and represents a direct threat to patient life and public health.
Reasons of extreme urgency — the MHRA recognises that its planned procurement process for the SafetyConnect programme, including the AI tool, would not have concluded by vaccine launch. Leading to an inability to effectively monitor adverse reactions to a Covid-19 vaccine.
Events unforeseeable — the Covid-19 crisis is novel and developments in the search of a Covid-19 vaccine have not followed any predictable pattern so far.